Restatement of Previously Issued Financial Statements (Details Narrative) - USD ($)	Jun. 30, 2016	Sep. 30, 2015
Temporary impairment		$ 41,333,361
Common stock, shares issued	5,746,386,628	4,232,931,345
Entest Biomedical, Inc.
Common stock, shares issued		8,066,667

The cumulative amount of credit losses recognized in earnings related to debt securities held for which a portion of an other than temporary impairment (OTTI) was recognized in other comprehensive income (a component of shareholders' equity).

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 8B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=SL6284393-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 8B
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=73527792&loc=SL6284393-111563

Name:	us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant